Xenetic Biosciences, Inc. (NASDAQ:XBIO) | WebDisclosure

Basculer en Français

8606	Companies
141168	Keywords
77088	Articles
75433	Press releases

Headlines Articles Press releases Xenetic Biosciences, Inc.

Home
Companies
Xenetic Biosciences, Inc.

BRIEF

published on 04/09/2025 at 15:20, 2 hours 5 minutes ago

Xenetic Biosciences partage des données précliniques prometteuses lors de la réunion du SITC

Biosciences Xénétiques Thérapie Cellulaire CAR-T Tumeurs Solides Données Précliniques Technologie DNase
BRIEF

published on 04/09/2025 at 15:20, 2 hours 5 minutes ago

Xenetic Biosciences Shares Promising Preclinical Data at SITC Meeting

Xenetic Biosciences Preclinical Data Solid Tumors DNase Technology CAR-T Cell Therapy
PRESS RELEASE

published on 04/09/2025 at 15:15, 2 hours 10 minutes ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Dr. Reid Bissonnette of Xenetic presents positive preclinical data on DNase I intervention enhancing CAR-T cell therapy in solid tumors at SITC 2025 Cell Therapy Meeting. Learn more at Xenetic's website

Immuno-oncology Xenetic DNase I SITC 2025 CAR-T Cell Therapy
BRIEF

published on 03/26/2025 at 14:05, 14 days 3 hours ago

Le partenaire de Xenetic Biosciences participe à une étude clinique pour développer sa plateforme DNase

Traitement Du Cancer Étude Clinique Biosciences Xénétiques Plateforme DNase Ostéosarcome
BRIEF

published on 03/26/2025 at 14:05, 14 days 3 hours ago

Xenetic Biosciences' Partner Enters Clinical Study to Advance DNase Platform

Xenetic Biosciences Cancer Treatment Clinical Study DNase Platform Osteosarcoma
PRESS RELEASE

published on 03/26/2025 at 14:00, 14 days 3 hours ago

Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma
Xenetic Biosciences, Inc. collaborates with PeriNess Ltd. on a clinical study at Tel-Aviv Sourasky Medical Center to evaluate DNase I candidate XBIO-015 in osteosarcoma and Ewing sarcoma patients

Xenetic Biosciences Clinical Study DNase I PeriNess Ltd. Osteosarcoma
BRIEF

published on 03/19/2025 at 13:10, 21 days 4 hours ago

Xenetic Biosciences Reports 2024 Financial Results

Financial Results Cancer Treatment Clinical Development Collaborations DNase Technology
BRIEF

published on 03/19/2025 at 13:10, 21 days 4 hours ago

Xenetic Biosciences publie ses résultats financiers pour 2024

Résultats Financiers Développement Clinique Collaborations Traitement Du Cancer Technologie DNase
PRESS RELEASE

published on 03/19/2025 at 13:05, 21 days 4 hours ago

Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results
Xenetic Biosciences reports encouraging preclinical data on DNase-based technology targeting NETosis for difficult cancers. Focus on clinical studies partnerships and DNase I development program for pancreatic carcinoma

Xenetic Biosciences Preclinical Data Clinical Studies DNase-based Technology NETosis
BRIEF

published on 03/13/2025 at 13:35, 27 days 3 hours ago

Xenetic Biosciences Reveals Promising Preclinical Data for DNase I in Cancer Therapy

Xenetic Biosciences Cancer Treatment Preclinical Data DNase I Therapy CAR T Cells

1 2 ... 7

Accesswire

Published on 04/09/2025 at 15:35, 1 hour 50 minutes ago

Le Cree Trappers Association, le Conseil de la sécurité économique des chasseurs cris et les sociétés d'exploration et minières approuvent le financement de 2025 pour poursuivre la reconstruction des camps incendiés lors des incendies de forêt de
Published on 04/09/2025 at 15:15, 2 hours 10 minutes ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 04/09/2025 at 15:00, 2 hours 25 minutes ago

The Cree Trappers Association, the Cree Hunters Economic Security Board and Mining & Exploration Companies Approve 2025 Funding to Continue the Reconstruction of Cabins Burnt During the 2023 Forest Fires, James Bay, Quebec
Published on 04/09/2025 at 15:00, 2 hours 25 minutes ago

Le Cree Trappers Association, le Conseil de la sécurité économique des chasseurs cris et les sociétés d'exploration et minières approuvent le financement de 2025 pour poursuivre la reconstruction des camps incendiés lors des incendies de forêt de
Published on 04/09/2025 at 15:00, 2 hours 25 minutes ago

The Cree Trappers Association, the Cree Hunters Economic Security Board and Mining & Exploration Companies Approve 2025 Funding to Continue the Reconstruction of Cabins Burnt during the 2023 Forest Fires, James Bay, Quebec

View all ACCESSWIRE

EQS Group

Published on 04/09/2025 at 17:11, 13 minutes ago

EQS-Adhoc: TRATON SE: Preliminary operating result for Q1 2025 below market expectations; Full-year outlook unchanged
Published on 04/09/2025 at 17:11, 14 minutes ago

Travis Perkins: Publication of Notice of Annual General Meeting to be held on Wednesday, 14 May 2025
Published on 04/09/2025 at 17:00, 25 minutes ago

Not Just a Sporting Event, but Also a Technological Test: Insights into the World's First Human-Robot Co-Run Marathon
Published on 04/09/2025 at 15:35, 1 hour 50 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 04/09/2025 at 15:34, 1 hour 51 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.

Les Echos

Published on 04/09/2025 at 15:50, 1 hour 35 minutes ago

Evolution mensuelle du 31 mars 2025
Published on 04/09/2025 at 11:24, 6 hours 1 minute ago

Electricité de Strasbourg - Avis de réunion AGO du 14 mai 2025 publié au BALO
Published on 04/09/2025 at 09:00, 8 hours 25 minutes ago

STEF : Avis de mise à disposition des comptes annuels 2024
Published on 04/09/2025 at 08:00, 9 hours 25 minutes ago

Museum Studio becomes a majority shareholder in Lord Cultural Resources
Published on 04/09/2025 at 08:00, 9 hours 25 minutes ago

Museum Studio devient actionnaire majoritaire de Lord Cultural Resources

View all LES ECHOS COMFI WIRE